$22.48
0.713.26%
At close: Sep 3, 5:00 PM EST
$22.48
N/A
After Hours: 4:00 PM EST
Latigo Biotherapeutics (LTGO) institutional and insider ownership, recent insider transactions and ownership breakdown.
Shares Outstanding
63.238M
Net Insider Activity by Month
Purchases (90d)
2
$5.0M total
Sales (90d)
0
Net Activity
Net Buying
Net Value (90d)
$5.0M
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Foresite Capital Management V LLC, Foresite Capital Fund V LP, Foresite Capital Opportunity Management V LLC, Foresite Capital Opportunity Fund V LP, Foresite Capital Management VI LLC, Foresite Capital Fund VI LP | 10% OWNER | BUY | 9.181M | $18.00 | $2.5M |
| Aug 10, 2026 | James Tananbaum | — | BUY | 9.181M | $18.00 | $2.5M |
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
